In fact, glucose-induced mesangial matrix remodelling has been suggested as a mechanism leading to nephropathy, and thus MMP-10 has been suggested as a potential drug target to slow down diabetic nephropathy and retinopathy (46). Here, MMP10 is linked to diabetic kidney disease.